OP-91 Transradial Catheterization Decreases the Radial Artery Luminal Diameter and Impairs Vasodilatation Response at the Access Site Late after the Intervention: an Observational Study

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-91 Transradial Catheterization Decreases the Radial Artery Luminal Diameter and Impairs Vasodilatation Response at the Access Site Late after the Intervention: an Observational Study

Objectives The present study aimed to evaluate the late term changes in radial artery luminal diameter (RAD) and vasodilatation response following transradial coronary intervention (TRI). Background TRI inducing a trauma…

read more

OP-88 Chronic Systolic (Left Ventricular low Ejection Fraction) Heart Failure; Plans of Management; Proper Patient, Selection for Every Plan

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-88 Chronic Systolic (Left Ventricular low Ejection Fraction) Heart Failure; Plans of Management; Proper Patient, Selection for Every Plan

Background Chronic heart failure is a common health problem with poor prognosis, high mortality rate and the incidence of this disease is increasing continuously. Prognosis of chronic systolic heart failure…

read more

OP-90 Increased Serum Lipid Levels on Admission is Associated with Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-90 Increased Serum Lipid Levels on Admission is Associated with Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

Objectives We aimed to evaluate the correlation between the pre-procedural serum lipid levels and the extent of periprocedural myocardial injury (PMI) in patients undergoing elective percutaneous coronary intervention (PCI). Background…

read more

OP-86 A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolactone Therapy

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-86 A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolactone Therapy

Objective It has been aimed to investigate the Galectin-3 (GAL-3) levels and clinical responses after addition of spironolactone as a mineralocorticoid receptor antagonist (MRA) to the current treatment in patients…

read more

OP-83 Demographics, Clinical Characteristics and One-year Mortality Results of the Patients with Non-ST-Elevation Acute Coronary Syndromes

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-83 Demographics, Clinical Characteristics and One-year Mortality Results of the Patients with Non-ST-Elevation Acute Coronary Syndromes

Purpose There is only limited data on long-term results for the patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) in Turkey. In the present study, we analyzed one-year follow-up results of…

read more

OP-82 Therapeutic Hypothermia in Cardiac Arrest Patients Undergoing Primary Coronary Intervention

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-82 Therapeutic Hypothermia in Cardiac Arrest Patients Undergoing Primary Coronary Intervention

Introduction Improved neurological outcomes have been reported after therapeutic hypothermia for comatose survivors of cardiac arrest. Therefore therapeutic hypothermia is indicated as soon as possible after resuscitation of cardiac arrest…

read more

OP-81 The Relationship between Alteration in QRS Fragmentation and in-Hospital Outcomes in Acute Myocardial Infarction Treated with Primary Percutenous Coronary Intervention

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-81 The Relationship between Alteration in QRS Fragmentation and in-Hospital Outcomes in Acute Myocardial Infarction Treated with Primary Percutenous Coronary Intervention

Objectives Fragmented QRS(fQRS), defined as additional spikes within the QRS complex, has been proven as an indicator of worse outcomes in a variety of cardiovascular disorders. However, the importance of…

read more
Get Clinical Tree app for offline access